Alterations in excitotoxicity and prostaglandin metabolism in a transgenic mouse model of Alzheimer's disease

Neurochemistry International

Volumn 55, Issue 7, 2009, Pages 689-696

  Schulte, Eva C ^a,b   Slawik, Helen ^a,b   Schüle, Roland ^a   Gunther, Thomas ^a   Hüll, Michael ^a,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cyclooxygenase; Kainate; Presenilin; Seizures

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GLUTAMIC ACID; PRESENILIN 2; PROSTAGLANDIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXCITOTOXICITY; HIPPOCAMPUS; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROTEIN EXPRESSION; WILD TYPE;

ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; CYCLOOXYGENASE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXCITATORY AMINO ACID AGONISTS; HUMANS; INJECTIONS, INTRAPERITONEAL; KAINIC ACID; MICE; MICE, TRANSGENIC; PRESENILIN-2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEIZURES;

MUS; MUS MUSCULUS;

EID: 69349095118     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.06.010     Document Type: Article

References (52)

1. Adams J., Collaco-Moraes Y., and de Belleroche J. Cyclooxygenase-2 induction in the cerebral cortex: an intracellular response to synaptic excitation. J. Neurochem. 66 (1996) 6-13
2. Aisen P.S. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol. 1 (2002) 279-284
3. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14 (1985) 375-403
4. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B.L., Pozzan T., and Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391 (1998) 281-285
5. Bilak M., Wu L., Wang Q., Haughey N., Conant K., St Hillaire C., and Andreasson K. PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann. Neurol. 56 (2004) 240-248
6. Bojarski L., Herms J., and Kuznicki J. Calcium dysregulation in Alzheimer's disease. Neurochem. Int. 52 (2008) 621-633
7. Cohn S.M., Schloemann S., Tessner T., Seibert K., and Stenson W.F. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J. Clin. Invest. 99 (1997) 1367-1379
8. Cuanjungco M.P., Goldstein L.E., Nuomoroa A., Smith M.A., Lim J.T., Atwood C.S., Huang X., Farrag Y.W., Perry G., and Bush A.I. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc. J. Biol. Chem. 275 (2000) 19439-19442
9. Ferkany J.W., Zaczek R., and Coyle J.T. The mechanism of kainic acid neurotoxicity. Nature 298 (1984) 757-759
10. Ferraro T.N., Golden G.T., Smith G.G., and Berrettini W.H. Differential susceptibility to seizures induced by systemic kainic acid treatment in mature DBA/2J and C57BL/6J mice. Epilepsia 36 (1995) 301-307
11. Fletcher B.S., Kujubu D.A., Perrin D.M., and Herschman H.R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267 (1992) 4338-4344
12. Ha S.K., Lee P., Park J.A., Oh H.R., Lee S.Y., Park J.H., Lee E.H., Ryu J.H., Lee K.R., and Kim S.Y. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced foal ischemia mouse model. Neurochem. Int. 52 (2008) 878-886
13. Hashimoto K., Watanabe K., Nishimura T., Iyo M., Shirayama Y., and Minabe Y. Behavioral changes and expression of a heat shock protein hsp-70 mRNA, brain-derived neurotrophic factor mRNA, and cyclooxygenase-2 mRNA in rat brain following seizures induced by systemic administration of kainic acid. Brain Res. 804 (1998) 212-223
14. Hüll M., Lieb K., and Fiebich B.L. Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs. Curr. Med. Chem. 9 (2002) 83-88
15. Hynd M.R., Scott H.L., and Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 45 (2004) 583-595
16. Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S., and Ross M.E. Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 1294-1299
17. In't Veld B.A., Ruitenberg A., Hofman A., Stricker B.H., and Breteler M.M. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol. Aging 22 (2001) 407-441
18. Kaplan M.D., Olschowka J.A., and O'Banion M.K. Cyclooxygenase-1 behaves as a delayed response gene in PC12 cells differentiated by nerve growth factor. J. Biol. Chem. 272 (1997) 18534-18537
19. Kawaguchi K., Hickey R.W., Rose M.E., Zhu L., Chen J., and Graham S.H. Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in the CA3 hippocampus. Brain Res. 1050 (2005) 130-137
20. Kelley K.A., Ho L., Winger D., Freire-Moar J., Borelli C.B., Aisen P.S., and Pasinetti G.M. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol. 155 (1999) 995-1004
21. Kim E.J., Lee J.E., Kwon K.J., Lee S.H., Moon C.H., and Baik E.J. Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E(2) production and neurodegeneration in cortical and hippocampal cell cultures. Brain Res. 908 (2001) 1-9
22. Kotti T., Tapiola T., Riekkinen P.J., and Miettinen R. The calretinin-containing mossy cells survive excitotoxic insult in the gerbil dentate gyrus. Comparision of excitotoxicity-induced neuropathological changes in the gerbil and rat. Eur. J. Neurosci. 8 (1996) 2371-2378
23. Leissring M.A., Yamasaki T.R., Wasco W., Buxbaum J.D., Parker I., and LaFerla F.M. Calsenilin reverses presenilin-mediated enhancement of calcium signaling. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 8590-8593
24. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., and Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 (1995) 973-977
25. McCullough L., Wu L., Haughey N., Liang X., Hand T., Wang Q., Breyer R.M., and Andreasson K. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J. Neurosci. 24 (2004) 257-268
26. McGeer P.L., Schulzer M., and McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47 (1996) 425-432
27. McKhann G.M., Wenzel H.J., Robbins C.A., Sosunov A.A., and Schwartzkroin P.A. Mouse strain differences in kainic acid sensitivity, seizure behavior, mortality, and hippocampal pathology. Neuroscience 122 (2003) 551-561
28. Michaelis E.K. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54 4 (1998) 369-415
29. Moore A.H., Olschowka J.A., and O'Banion M.K. Intraparenchymal administration of interleukin-1beta induces cyclooxygenase-2-mediated expression of membrane- and cytosolic-associated prostaglandin E synthases in mouse brain. J. Neuroimmunol. 148 (2004) 32-40
30. Montine T.J., Milatovic D., Gupta R.C., Valyi-Nagy T., Morrow J.D., and Breyer R.M. Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J. Neurochem. 83 (2002) 463-470
31. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., and Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 (2000) 98-103
32. Oyama F., Sawamura N., Kobayashi K., Morishima-Kawashima M., Kuramochi T., Ito M., Tomita T., Maruyama K., Saido T.C., Iwatsubo T., Capell A., Walter J., Grunberg J., Ueyama Y., Haass C., and Ihara Y. Mutant presenilin-2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain. J. Neurochem. 71 (1998) 313-322
33. Parente L., and Perretti M. Advances in the pathophysiology of constituitive and inducive cyclooxygenases: two enzymes in the spotlight. Biochem. Pharmacol. 65 (2003) 153-159
34. Qin W., Peng Y., Ksiezak-Reding H., Ho L., Stetka B., Lovati E., and Pasinetti G.M. Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease. Mol. Psychiatry 11 (2006) 172-181
35. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., and Tsuda T. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376 (1995) 775-778
36. Sang N., Zhang J., Marcheselli V., Bazan N.G., and Chen C. Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J. Neurosci. 25 (2005) 9858-9870
37. Saura C.A., Choi S.Y., Beglopoulos V., Malkani S., Zhang D., Shankaranarayana Rao B.S., Chattarji S., Kelleher R.J., Kandel E.R., Duff K., Kirkwood A., and Shen J. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42 (2004) 23-36
38. Sawamura N., Morishima-Kawashima M., Waki H., Kobayashi K., Kuramochi T., Frosch M.P., Ding K., Ito M., Kim T.W., Tanzi R.E., Oyama F., Tabira T., Ando S., and Ihara Y. Mutant presenilin 2 transgenic mice. A large increase in the levels of Abeta 42 is presumably associated with the low density membrane domain that contains decreased levels of glycerophospholipids and sphingomyelin. J. Biol. Chem. 275 (2000) 27901-27908
39. Schauwecker P.E., and Steward O. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4103-4108
40. Schauwecker P.E., Ramirez J.J., and Steward O. Genetic dissection of the signals that induce synaptic reorganization. Exp. Neurol. 161 (2000) 139-152
41. Schneider I., Reverse D., Dewachter I., Ris L., Caluwaerts N., Kuiperi C., Gilis M., Geerts H., Kretzschmar H., Godaux E., Moechars D., Van Leuven F., and Herms J. Mutant presenlins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J. Biol. Chem. 276 (2001) 11539-11544
42. Shen J., and Kelleher R.J. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc. Natl. Acad. Sci. 104 (2007) 403-409
43. Smith M.A., and Perry G. Causes and consequences of oxidative stress in Alzheimer's disease. Free Rad. Biol. Med. 22 (2002) 1194-1199
44. Takadera T., Shiraishi Y., and Ohyashiki T. Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons. Neurochem. Int. 45 (2004) 713-719
45. Takadera T., and Ohyashiki T. Prevention of rat cortical neurons from prostaglandin E2-induced apoptosis by glycogen synthase kinase-3 inhibitors. Neurosci. Lett. 400 (2006) 105-109
46. Takemiya T., Suzuki K., Sugiura H., Yasuda S., Yamagata K., Kawakami Y., and Maru E. Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Other Lipid Mediat. 71 (2003) 205-216
47. Takemiya T., Matsumura K., and Yamagata K. Roles of prostaglandin synthesis in excitotoxic brain diseases. Neurochem. Int. 51 (2007) 112-120
48. Wong P.T., McGeer P.L., and McGeer E.G. Decreased prostaglandin synthesis in postmortem cerebral cortex from patients with Alzheimer's disease. Neurochem. Int. 21 (1992) 197-202
49. Xie W., Fletcher B.S., Andersen R.D., and Herschman H.R. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol. Cell Biol. 14 (1994) 6531-6539
50. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-386
51. Yoo A.S., Cheng I., Chung S., Grenfell T.Z., Lee H., Pack-Chung E., Handler M., Shen J., Xia W., Tesco G., Saunders A.J., Ding K., Frosch M.P., Tanzi R.E., and Kim T.W. Presenilin-mediated modulation of capacitative calcium entry. Neuron 27 (2000) 561-572
52. Yukioka F., Matsuzaki S., Kawamoto K., Koyama Y., Hitomi J., Katayama T., and Tohyama M. Presenilin-1 mutation activates the signaling pathway of caspase-4 in endoplasmic reticulum stress-induced apoptosis. Neurochem. Int. 52 (2008) 683-687